Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer.

Pedersen JW, Gentry-Maharaj A, Fourkala EO, Dawnay A, Burnell M, Zaikin A, Pedersen AE, Jacobs I, Menon U, Wandall HH.

Br J Cancer. 2013 Jan 15;108(1):107-14. doi: 10.1038/bjc.2012.517. Epub 2012 Nov 20.

2.

Clinical decision support and individualized prediction of survival in colon cancer: bayesian belief network model.

Stojadinovic A, Bilchik A, Smith D, Eberhardt JS, Ward EB, Nissan A, Johnson EK, Protic M, Peoples GE, Avital I, Steele SR.

Ann Surg Oncol. 2013 Jan;20(1):161-74. doi: 10.1245/s10434-012-2555-4. Epub 2012 Aug 17.

PMID:
22899001
3.

Health insurer policies toward risk-stratified colorectal cancer screening: a survey of health plan medical directors.

Ramsey SD, McDermott CL, Clarke L, Blough DK.

J Insur Med. 2012;43(2):92-101.

PMID:
22876413
4.

Screening computed tomography colonography with 256-slice scanning: should patient radiation burden and associated cancer risk constitute a major concern?

Perisinakis K, Seimenis I, Tzedakis A, Papadakis AE, Kourinou KM, Damilakis J.

Invest Radiol. 2012 Aug;47(8):451-6. doi: 10.1097/RLI.0b013e318250a58c.

PMID:
22766908
5.

Immunoliposome-PCR: a generic ultrasensitive quantitative antigen detection system.

He J, Evers DL, O'Leary TJ, Mason JT.

J Nanobiotechnology. 2012 Jun 22;10(1):26. doi: 10.1186/1477-3155-10-26.

6.

Role of DNA methylation in colorectal carcinogenesis.

Patai AV, Molnár B, Kalmár A, Schöller A, Tóth K, Tulassay Z.

Dig Dis. 2012;30(3):310-5. doi: 10.1159/000337004. Epub 2012 Jun 20. Review.

PMID:
22722557
7.

Gut stem cells in tissue renewal and disease: methods, markers, and myths.

Rizk P, Barker N.

Wiley Interdiscip Rev Syst Biol Med. 2012 Sep-Oct;4(5):475-96. doi: 10.1002/wsbm.1176. Epub 2012 May 29. Review.

PMID:
22644962
8.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team.

N Engl J Med. 2012 Jun 21;366(25):2345-57. doi: 10.1056/NEJMoa1114635. Epub 2012 May 21.

9.

High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.

Li BS, Wang XY, Xu AG, Ma FL, Ma QY, Li Z, Liu JH, Gan AH, Yu ZJ, Zhang XH, Jiang B.

Clin Colorectal Cancer. 2012 Dec;11(4):280-90. doi: 10.1016/j.clcc.2012.04.001. Epub 2012 May 18.

PMID:
22609129
10.

Human POLB gene is mutated in high percentage of colorectal tumors.

Donigan KA, Sun KW, Nemec AA, Murphy DL, Cong X, Northrup V, Zelterman D, Sweasy JB.

J Biol Chem. 2012 Jul 6;287(28):23830-9. doi: 10.1074/jbc.M111.324947. Epub 2012 May 10.

11.

Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.

Jang SH, Min KW, Paik SS, Jang KS.

J Clin Pathol. 2012 Aug;65(8):735-9. doi: 10.1136/jclinpath-2012-200685. Epub 2012 May 3.

PMID:
22554968
12.

Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization.

Damania D, Roy HK, Subramanian H, Weinberg DS, Rex DK, Goldberg MJ, Muldoon J, Cherkezyan L, Zhu Y, Bianchi LK, Shah D, Pradhan P, Borkar M, Lynch H, Backman V.

Cancer Res. 2012 Jun 1;72(11):2720-7. doi: 10.1158/0008-5472.CAN-11-3807. Epub 2012 Apr 6.

13.

Promoter CpG island methylation markers in colorectal cancer: the road ahead.

Draht MX, Riedl RR, Niessen H, Carvalho B, Meijer GA, Herman JG, van Engeland M, Melotte V, Smits KM.

Epigenomics. 2012 Apr;4(2):179-94. doi: 10.2217/epi.12.9. Review.

PMID:
22449189
14.

Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3).

Adler A, Wegscheider K, Lieberman D, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Mroß M, Scheel M, Schröder A, Gerber K, Stange G, Roll S, Gauger U, Wiedenmann B, Altenhofen L, Rosch T.

Gut. 2013 Feb;62(2):236-41. doi: 10.1136/gutjnl-2011-300167. Epub 2012 Mar 22.

PMID:
22442161
15.

Prediction in rectal cancer.

Zeestraten EC, Kuppen PJ, van de Velde CJ, Marijnen CA.

Semin Radiat Oncol. 2012 Apr;22(2):175-83. doi: 10.1016/j.semradonc.2011.12.005. Review.

PMID:
22385923
16.

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD.

N Engl J Med. 2012 Feb 23;366(8):687-96. doi: 10.1056/NEJMoa1100370.

17.
18.

Colorectal cancer screening of high-risk populations: A national survey of physicians.

White PM, Sahu M, Poles MA, Francois F.

BMC Res Notes. 2012 Jan 24;5:64. doi: 10.1186/1756-0500-5-64.

19.

Cancer statistics, 2012.

Siegel R, Naishadham D, Jemal A.

CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.

20.

Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008.

Siegel RL, Ward EM, Jemal A.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):411-6. doi: 10.1158/1055-9965.EPI-11-1020. Epub 2012 Jan 4.

Supplemental Content

Support Center